Venous thromboembolism following gynaecological surgery for suspected or confirmed malignancy

Australian and New Zealand Journal of Obstetrics and Gynaecology

Volumn 52, Issue 1, 2012, Pages 23-27

  Hitos, Kerry ^a   Wain, Gerard V ^b   Fletcher, John P ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b WESTMEAD HOSPITAL   (Australia)

Author keywords

gynaecology; heparin; low molecular weight heparin; malignancy; surgery; warfarin

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; DALTEPARIN; ENOXAPARIN; HEPARIN; NONSTEROID ANTIINFLAMMATORY AGENT;

ACIDOSIS; ACUTE KIDNEY FAILURE; ADULT; ARTICLE; BLEEDING; CHEMOTHERAPY; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DATA ANALYSIS; DEEP VEIN THROMBOSIS; FEMALE; GYNECOLOGIC SURGERY; HEMATOLOGIC MALIGNANCY; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; INCIDENCE; LENGTH OF STAY; LUNG EMBOLISM; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; RETROSPECTIVE STUDY; RISK; RISK FACTOR; SEPSIS; THROMBOCYTOPENIA; VARICOSIS;

ADULT; COHORT STUDIES; FEMALE; GENITAL NEOPLASMS, FEMALE; GYNECOLOGIC SURGICAL PROCEDURES; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; INCIDENCE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PULMONARY EMBOLISM; RETROSPECTIVE STUDIES; RISK FACTORS; VENOUS THROMBOEMBOLISM; VENOUS THROMBOSIS;

EID: 84856975265     PISSN: 00048666     EISSN: 1479828X     Source Type: Journal    
DOI: 10.1111/j.1479-828X.2011.01353.x     Document Type: Article

References (21)

1. Crandon AJ, Koutts J,. Incidence of post-operative deep vein thrombosis in gynaecological oncology. Aust N Z J Obstet Gynaecol 1983; 23: 216-219. (Pubitemid 14158911)
2. Ballard RM, Bradley-Watson PJ, Johnstone FD, et al., Low doses of subcutaneous heparin in the prevention of deep vein thrombosis after gynaecological surgery. J Obstet Gynaecol Br Commonw 1973; 80: 469-472.
3. Taberner DA, Poller L, Burslem RW, Jones JB,. Oral anticoagulants controlled by the British comparative thromboplastin versus low-dose heparin in prophylaxis of deep vein thrombosis. Br Med J 1978; 1: 272-274. (Pubitemid 8316106)
4. von Tempelhoff GF, Nieman F, Heilmann L, Hommel G,. Association between blood rheology, thrombosis and cancer survival in patients with gynecologic malignancy. Clin Hemorheol Microcirc 2000; 22: 107-130. (Pubitemid 30224991)
5. Geerts WH, Pineo GF, Heit JA, et al., Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126: 338S-400S. (Pubitemid 39302602)
6. Clarke-Pearson DL, DeLong ER, Synan IS, et al., Variables associated with postoperative deep venous thrombosis: a prospective study of 411 gynecology patients and creation of a prognostic model. Obstet Gynecol 1987; 69: 146-150. (Pubitemid 17015523)
7. Geerts WH, Bergqvist D, Pineo GF, et al., Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133: 381S-453S. (Pubitemid 351894916)
8. Heilmann L, von Tempelhoff GF, Schneider D,. Prevention of thrombosis prophylaxis in gynecologic malignancy. Clin Appl Thromb Hemost 1998; 4: 153-159. (Pubitemid 28293043)
9. Clarke-Pearson DL, Synan IS, Dodge R, et al., A randomized trial of low-dose heparin and intermittent pneumatic calf compression for the prevention of deep venous thrombosis after gynecologic oncology surgery. Am J Obstet Gynecol 1993; 168: 1146-1153; discussion 53-4.
10. Urlep-Salinovic V, Jelatancev B, Gorisek B,. Low doses of heparin and heparin dihydergot in postoperative thromboprophylaxis in gynaecological patients. Thromb Haemost 1994; 72: 16-20. (Pubitemid 24202288)
11. Ward B, Pradhan S,. Comparison of low molecular weight heparin (Fragmin) with sodium heparin for prophylaxis against postoperative thrombosis in women undergoing major gynaecological surgery. Aust N Z J Obstet Gynaecol 1998; 38: 91-92. (Pubitemid 28077501)
12. Baykal C, Al A, Demirtas E, Ayhan A,. Comparison of enoxaparin and standard heparin in gynaecologic oncologic surgery: a randomised prospective double-blind clinical study. Eur J Gynaecol Oncol 2001; 22: 127-130. (Pubitemid 32963064)
13. Maxwell GL, Synan I, Dodge R, et al., Pneumatic compression versus low molecular weight heparin in gynecologic oncology surgery: a randomized trial. Obstet Gynecol 2001; 98: 989-995. (Pubitemid 34075320)
14. Schorge JO, Goldhaber SZ, Duska LR, et al., Clinically significant venous thromboembolism after gynecologic surgery. J Reprod Med 1999; 44: 669-673. (Pubitemid 29409877)
15. ENOXACAN Study Group. Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery: a double-blind randomized multicentre trial with venographic assessment. Br J Surg 1997; 84: 1099-1103.
16. Cohen AT, Wagner MB, Mohamed MS,. Risk factors for bleeding in major abdominal surgery using heparin thromboprophylaxis. Am J Surg 1997; 174: 1-5. (Pubitemid 27343849)
17. Bergqvist D, Agnelli G, Cohen AT, et al., Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer. N Engl J Med 2002; 346: 975-980. (Pubitemid 34983247)
18. Rasmussen MS, Jorgensen LN, Wille-Jorgensen P,. Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery. Cochrane Database Syst Rev 2009; (1): Art. No.: CD004318.
19. National Institute for Health and Clinical Excellence. Reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in inpatients undergoing surgery. 2010:.
20. Agnelli G, Bolis G, Capussotti L, et al., A clinical outcome-based prospective study on venous thromboembolism after cancer surgery: the @RISTOS project. Ann Surg 2006; 243: 89-95. (Pubitemid 43054059)
21. Giannice R, Foti E, Poerio A, et al., Perioperative morbidity and mortality in elderly gynecological oncological patients (>/= 70 Years) by the American Society of Anesthesiologists physical status classes. Ann Surg Oncol 2004; 11: 219-225. (Pubitemid 40486800)